Slate Bio Launches with Seed Financing to Develop Next Generation IL-2 Therapies
January 19, 2021
CHARLOTTESVILLE, Va. —Slate Bio, Inc., announced today the closing of a $1.75 million venture financing. Epidarex Capital led the investment round with participation from the UVA